Motion and IntraCoronary Ecg Ischemia Development Study (MICE)
Study Details
Study Description
Brief Summary
The concept of the "ischemic cascade" is generally accepted hypothesis, according to which whenever ischemia of the myocardium occurs there is a consequence of events, that always occur in a given order - diastolic dysfunction first, followed by systolic dysfunction, then changes on electrocardiogram (ECG) and finally chest pain sensation. The occurrence of every next stage of cascade means more severe ischemia and respectively - more severe myocardial damage. We propose that mechanical and electrical changes in the myocardium during ischemia appear simultaneously.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The development of an ischemic event, whether silent or painful, represents the cumulative impact of a sequence of pathophysiologic events. Each ischemic episode is initiated by an imbalance between myocardial oxygen supply and demand that may ultimately be manifested as angina pectoris. The ischaemic cascade is the concept that progressive myocardial oxygen supply-demand mismatch causes a consistent sequence of events, starting with metabolic alterations and followed sequentially by myocardial perfusion abnormalities, wall motion abnormalities, ECG changes, and angina. This concept would suggest that investigations that detect expressions of ischaemia earlier in the cascade should be more sensitive tests of ischaemia than those that detect expressions appearing later in the cascade.Visualization of a regional decrease in the systolic movement of the endocardium and a decrease in myocardial thickening are the main principles for the diagnosis of myocardial damage. However, the concept of ischaemic cascade is entirely based on clinical observations. It is not clear, which changes (mechanical or electrical) appear first during an episode of ischemia and which are prognostically more important. The objective of this study is to compare ischemic cascade towards ischemic constellation regarding beginning, duration and sequence of the electric, kinetic and haemodynamic signs of ischemia by FFR, icECG and wall motion abnormalities sign (M-sign - deformation and shortening of the wire tip) in patients with coronary bifurcation stenosis
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patients with coronary bifurcation lesions Patients from 18 to 90-years old with coronary bifurcation lesions with significant >50% diameter stenosis artery scheduled for intervention of the main vessel (Medina types: 1x1, x11, 111) |
Procedure: Percutaneous coronary intervention with FFR measurement and intracoronary ECG registration
Measurement of fractional flow reserve (FFR), registration of intracoronary ECG and radioscopic registration of wire tip movement in the main and in the side branch in the beginning, at the end and during every step of coronary bifurcation percutaneous intervention.
|
Outcome Measures
Primary Outcome Measures
- Side branch region ischemia [Percutaneous coronary intervention procedure time (up to 4 hours)]
Beginning, duration, sequence of the electric, kinetic and haemodynamic signs of ischemia, comparison between ischemic cascade and constellation.
Secondary Outcome Measures
- Target lesion revascularization [12 months]
Any revascularization at the territory of previously intervention
- Number of patients not alive [12 months]
Number of patients not alive
- Myocardial infarction after hospital discharge [12 months]
Myocardial infarction according to universal definition of MI - CK-MB > 2xULN +/- symptoms +/- surface ECG changes in at least 2 leads
- New onset angina or heart failure symptoms [12 months]
New onset angina symptoms of at least CCS class II; New onset dyspnea at exertion or at rest
Other Outcome Measures
- Periprocedural myonecrosis - extent of post PCI enzyme elevation [48 hours]
Troponin I elevation 1-3; 3-5; >5 x ULN Creatin phosphokinase MB fraction elevation 1-3; 3-5; >5 x ULN
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Subject at least 18 years of age.
-
Subject able to verbally confirm understandings of risks, benefits of receiving PCI for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
-
Target main branch lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. Target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
-
Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.
Exclusion Criteria:
-
Subjects with significant ST-T change (≥ 1mm).
-
Non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
-
Subjects who refuse to give informed consent.
-
Subjects with the following angiographic characteristics: left main coronary artery stenosis, total occlusion before occurrence of SB, lesion of interest located at infarct-related artery.
-
Subjects with LVEF < 30%.
-
Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy.
-
LBBB, RBBB, atrial fibrillation/flutter with no identifiable isoelectric line.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Alexandrovska University Hospital | Sofia | Bulgaria |
Sponsors and Collaborators
- University National Heart Hospital
Investigators
- Principal Investigator: Dobrin Vassilev, Principal Investigator
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MICE-102019